161 related articles for article (PubMed ID: 34809518)
1. Biallelic Mutations in Ubiquitin-Specific Peptidase 53 (
Vij M; Sankaranarayanan S
Pediatr Dev Pathol; 2022; 25(2):207-212. PubMed ID: 34809518
[TBL] [Abstract][Full Text] [Related]
2. A novel homozygous mutation in the USP53 gene as the cause of benign recurrent intrahepatic cholestasis in children: a case report.
Ateş BB; Ceylan AC; Hızal G; Duran F; Doğan HT; Hızlı Ş
Turk J Pediatr; 2023; 65(6):1012-1017. PubMed ID: 38204320
[TBL] [Abstract][Full Text] [Related]
3. Cholestasis Due to USP53 Deficiency.
Bull LN; Ellmers R; Foskett P; Strautnieks S; Sambrotta M; Czubkowski P; Jankowska I; Wagner B; Deheragoda M; Thompson RJ
J Pediatr Gastroenterol Nutr; 2021 May; 72(5):667-673. PubMed ID: 33075013
[TBL] [Abstract][Full Text] [Related]
4. Low-GGT intrahepatic cholestasis associated with biallelic USP53 variants: Clinical, histological and ultrastructural characterization.
Zhang J; Yang Y; Gong JY; Li LT; Li JQ; Zhang MH; Lu Y; Xie XB; Hong YR; Yu Z; Knisely AS; Wang JS
Liver Int; 2020 May; 40(5):1142-1150. PubMed ID: 32124521
[TBL] [Abstract][Full Text] [Related]
5. Progressive Familial Intrahepatic Cholestasis Associated With USP53 Gene Mutation in a Brazilian Child.
Porta G; Rigo PSM; Porta A; Pugliese RPS; Danesi VLB; Oliveira E; Borges CCV; Ribeiro C; Miura IK
J Pediatr Gastroenterol Nutr; 2021 May; 72(5):674-676. PubMed ID: 33661244
[TBL] [Abstract][Full Text] [Related]
6. A Two-Year Clinical Description of a Patient with a Rare Type of Low-GGT Cholestasis Caused by a Novel Variant of
Shatokhina O; Semenova N; Demina N; Dadali E; Polyakov A; Ryzhkova O
Genes (Basel); 2021 Oct; 12(10):. PubMed ID: 34681012
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic yield and novel candidate genes by next generation sequencing in 166 children with intrahepatic cholestasis.
Zheng Y; Guo H; Chen L; Cheng W; Yan K; Zhang Z; Li M; Jin Y; Hu G; Wang C; Zhou C; Zhou W; Jia Z; Zheng B; Liu Z
Hepatol Int; 2024 Apr; 18(2):661-672. PubMed ID: 37314652
[TBL] [Abstract][Full Text] [Related]
8. New paradigms of USP53 disease: normal GGT cholestasis, BRIC, cholangiopathy, and responsiveness to rifampicin.
Alhebbi H; Peer-Zada AA; Al-Hussaini AA; Algubaisi S; Albassami A; AlMasri N; Alrusayni Y; Alruzug IM; Alharby E; Samman MA; Ayoub SZ; Maddirevula S; Peake RWA; Alkuraya FS; Wali S; Almontashiri NAM
J Hum Genet; 2021 Feb; 66(2):151-159. PubMed ID: 32759993
[TBL] [Abstract][Full Text] [Related]
9. Compound Heterozygous Myosin 5B (Myo5b) Mutation with Early Onset Progressive Cholestasis and No Intestinal Failure.
Vij M; Shah V
Fetal Pediatr Pathol; 2022 Oct; 41(5):811-817. PubMed ID: 34338607
[No Abstract] [Full Text] [Related]
10. The First Korean Adult Case of Progressive Familial Intrahepatic Cholestasis Type 7 with Novel
Ahn S; Choi J; Jeong SH
Yonsei Med J; 2023 Dec; 64(12):745-749. PubMed ID: 37992747
[TBL] [Abstract][Full Text] [Related]
11. Biallelic Novel
Gezdirici A; Kalaycik Şengül Ö; Doğan M; Özgüven BY; Akbulut E
Mol Syndromol; 2023 Jan; 13(6):471-484. PubMed ID: 36660033
[TBL] [Abstract][Full Text] [Related]
12. Heterozygous mutations of ATP8B1, ABCB11 and ABCB4 cause mild forms of Progressive Familial Intrahepatic Cholestasis in a pediatric cohort.
Mínguez Rodríguez B; Molera Busoms C; Martorell Sampol L; García Romero R; Colomé Rivero G; Martín de Carpi J
Gastroenterol Hepatol; 2022 Oct; 45(8):585-592. PubMed ID: 34942279
[TBL] [Abstract][Full Text] [Related]
13. Identification of novel loci for pediatric cholestatic liver disease defined by KIF12, PPM1F, USP53, LSR, and WDR83OS pathogenic variants.
Maddirevula S; Alhebbi H; Alqahtani A; Algoufi T; Alsaif HS; Ibrahim N; Abdulwahab F; Barr M; Alzaidan H; Almehaideb A; AlSasi O; Alhashem A; Hussaini HA; Wali S; Alkuraya FS
Genet Med; 2019 May; 21(5):1164-1172. PubMed ID: 30250217
[TBL] [Abstract][Full Text] [Related]
14. Biallelic loss-of-function
Luan W; Hao CZ; Li JQ; Wei Q; Gong JY; Qiu YL; Lu Y; Shen CH; Xia Q; Xie XB; Zhang MH; Abuduxikuer K; Li ZD; Wang L; Xing QH; Knisely AS; Wang JS
J Med Genet; 2021 Aug; 58(8):514-525. PubMed ID: 32737136
[TBL] [Abstract][Full Text] [Related]
15. Severe Neonatal Presentation of Progressive Familial Intrahepatic Cholestasis Type 4 in an Omani Infant.
Al Housni S; Al-Thihli K; Rahmatalla D; Wali Y; Al Rawahi Y
Sultan Qaboos Univ Med J; 2023 Nov; 23(4):543-546. PubMed ID: 38090248
[TBL] [Abstract][Full Text] [Related]
16. Late-Onset Drug-Induced Cholestasis in a Living-Related Liver Transplant Donor With Progressive Familial Intrahepatic Cholestasis.
Harmancı Ö; Ensaroğlu F; Özçay F; Öcal S; Korkmaz M; Özdemir BH; Selçuk H; Moray G; Haberal M
Exp Clin Transplant; 2015 Nov; 13 Suppl 3():107-9. PubMed ID: 26640927
[TBL] [Abstract][Full Text] [Related]
17. [Clinical and genetic analysis of cases of progressive familial intrahepatic cholestasis type 3].
Shen YL; Zhang XT; Xun YH
Zhonghua Gan Zang Bing Za Zhi; 2023 Mar; 31(3):307-313. PubMed ID: 37137858
[No Abstract] [Full Text] [Related]
18. Deleterious Variants in ABCC12 are Detected in Idiopathic Chronic Cholestasis and Cause Intrahepatic Bile Duct Loss in Model Organisms.
Pham DH; Kudira R; Xu L; Valencia CA; Ellis JL; Shi T; Evason KJ; Osuji I; Matuschek N; Pfuhler L; Mullen M; Mohanty SK; Husami A; Bull LN; Zhang K; Wali S; Yin C; Miethke A
Gastroenterology; 2021 Jul; 161(1):287-300.e16. PubMed ID: 33771553
[TBL] [Abstract][Full Text] [Related]
19. MYO5B Gene Mutations: A Not Negligible Cause of Intrahepatic Cholestasis of Infancy With Normal Gamma-Glutamyl Transferase Phenotype.
Matarazzo L; Bianco AM; Athanasakis E; Serveres M; Francalanci P; Cenacchi G; Maggiore G; D'Adamo AP
J Pediatr Gastroenterol Nutr; 2022 May; 74(5):e115-e121. PubMed ID: 35129155
[TBL] [Abstract][Full Text] [Related]
20. Panel-Based Next-Generation Sequencing for the Diagnosis of Cholestatic Genetic Liver Diseases: Clinical Utility and Challenges.
Chen HL; Li HY; Wu JF; Wu SH; Chen HL; Yang YH; Hsu YH; Liou BY; Chang MH; Ni YH
J Pediatr; 2019 Feb; 205():153-159.e6. PubMed ID: 30366773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
